Robotic exoskeletons go home: can daily wear change life after spinal cord injury?

NCT ID NCT07030322

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 11, 2026 · Last updated Sep 11, 2026

Summary

Researchers are observing five people with spinal cord injury who have a personal robotic exoskeleton for walking. The study tracks how often and how long participants use the device at home and in the community over 12 months. It also measures changes in health, bladder and bowel function, pain, mental health, and healthcare costs. Participants use the exoskeleton as they wish, with no required number of sessions.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a personal overground robotic exoskeleton (Ekso Indego Personal)
What this could lead to
If the device proves practical and beneficial over a year, it could support wider insurance coverage and daily home use for people with spinal cord injury.
What could go wrong
This is a tiny observational case study of five people, so results may not apply broadly. Participants must meet strict physical requirements, and the study does not test whether the exoskeleton causes better health, only whether patterns appear.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 5 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Ekso Bionics Clinical team will identify ambassadors with SCI who are interested in attaining an Indego device.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Femur lengths from 14.5" to 19" (35.5cm to 47 cm) * Healthy bone density * Height from 5'1" to 6'3" (1.5 to 1.9 m) * Seated hip width ≤ 16.6" (42.2 cm) * Sufficient upper extremity strength to manage approved stability aids * Weight 250 lbs or less * Availability of a support person able to complete training and be present during all Indego sessions Exclusion Criteria: * Cognitive impairments resulting in inability to follow directions * Colostomy bag * Diminished standing tolerance caused by orthostatic hypotension * Heterotopic ossification * Hip or knee contractures greater than 10° or ankle contractures greater than 5° * History of severe neurological injuries other than SCI (multiple sclerosis, --cerebral palsy, amyotrophic lateral sclerosis, traumatic brain injury, etc). * Lower limb prothesis * Poor skin integrity in areas in contact with the device * Pregnancy * Psychiatric conditions that may interfere with proper operation of the device * Severe concurrent medical diseases: infections, circulatory, heart or lung, pressure sores * Severe or uncontrolled spasticity (Modified Ashworth 4) * Spinal instability or spinal orthotics * Uncontrolled autonomic dysreflexia * Uncontrolled hypertension or hypotension * Unhealed limb or pelvic fractures * Unresolved deep vein thrombosis * Any condition which in the opinion of a medical doctor prevents the user from using the device

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Spinal cord injury are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ekso Bionics, Inc.

    San Rafael, California, 94901, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.